Craig Bottomley
Geen lopende functies
Loopbaan van Craig Bottomley
Eerdere bekende functies van Craig Bottomley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| STAR COMBO PHARMA LIMITED | Directeur/Bestuurslid | 17-04-2019 | 16-08-2019 |
| BWX | Directeur/Bestuurslid | 26-04-2013 | 02-03-2017 |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Directeur/Bestuurslid | 28-11-2005 | 22-11-2010 |
| Operationeel Directeur | 26-10-2009 | 22-11-2010 | |
| Oprichter | 28-11-2005 | 22-11-2010 | |
| MAYNE PHARMA GROUP LIMITED | Directeur/Bestuurslid | 28-11-2005 | 29-07-2010 |
| Operationeel Directeur | 28-11-2005 | 29-07-2010 | |
| GUD HOLDINGS LIMITED | Algemeen Directeur | - | - |
| Pacific Dunlop Cables Group | Algemeen Directeur | - | - |
| MIRRABOOKA INVESTMENTS LIMITED | Directeur/Bestuurslid | - | - |
Statistieken
Internationaal
| Australië | 8 |
Operationeel
| Director/Board Member | 5 |
| Chief Operating Officer | 2 |
| Chief Executive Officer | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
| Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| BWX | Consumer Non-Durables |
| GUD HOLDINGS LIMITED | Consumer Durables |
| STAR COMBO PHARMA LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
| Pacific Dunlop Cables Group |
- Beurs
- Insiders
- Craig Bottomley
- Ervaring
